Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

Resuscitec GmbH präsentiert sich auf der Jahrestagung des European Resuscitation Councils in Antwerpen

Die Resuscitec GmbH hat sich am 16. und 17.06.2022 bei der Jahrestagung des European Resuscitation Councils (ERC) Congress in Antwerpen mit einem eigenen Stand erfolgreich vorgestellt. 

Viele Interessierte aus verschiedenen Kliniken in Europa konnten das CARL System live vor Ort kennenlernen und spezifische Fragen mit dem CARL Support und Vertriebsteam diskutieren.

Am CARL Messestand konnten sich die Besucher des Kongresses über CARL informieren.

Univ.-Prof. Dr. Dr. h. c. Friedhelm Beyersdorf, ehemaliger Ärztlicher Direktor der Herz- und Gefäßchirurgie am Universitätsklinikum Freiburg, hat vor Ort einen Vortrag zum Thema ‘Controlled Automated Reperfusion of the whoLe body‘ gehalten.

Jan-Steffen Pooth, Arzt am Universitätsklinikum Freiburg, referierte anlässlich einer Session zu den Themen „Serum proteome alterations during conventional and extracorporeal resuscitation in pigs“ und „Visualization of cerebral blood flow in extracorporeal cardiopulmonary resuscitation in a porcine model of prolonged cardiac arrest“.

< Zurück